Journal News

Glutathione pathway implicated in rare disease

Pearce Hyatt
By Pearce Hyatt
March 19, 2026

Methylmalonic aciduria, or MMA, is a rare inherited metabolic disorder in which the body cannot break down certain amino acids and lipids. This leads to a buildup of methylmalonic acid and other metabolites in tissues and body fluids, and is associated with conditions like oxidative stress and mitochondrial dysfunction. However, MMA’s complex underlying mechanisms of action remain unresolved.

Integrative multiomics has emerged as a tool to help better understand the underlying pathogenesis of the disease. Jianbo Fu, Sandra Goetze and a team of researchers in Switzerland provide an analysis framework to integrate complex data types. They published their framework in Molecular & Cellular Proteomics.

The team obtained DNA, RNA, protein and metabolite information from MMA patients. Using their multiomics framework, which links genetic variants to protein levels, they identified glutathione metabolism as a central pathway in MMA pathogenesis.

This study illustrates how multiomics approaches can reveal underlying mechanisms in complex diseases, highlighting potential targets for future therapeutic strategies.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Pearce Hyatt
Pearce Hyatt

Pearce Hyatt is an incoming medical student at Wake Forest School of Medicine. He spent two years working at the Laboratory of Viral Diseases at the National Institutes of Health and is an ASBMB Today volunteer contributor.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

Light-activated small molecule could transform eye infection treatment
News

Light-activated small molecule could transform eye infection treatment

April 21, 2026

Contact lenses raise the risk of infectious keratitis, a leading cause of blindness worldwide. A biotech company is commercializing a light-activated therapy using a ROS-generating molecule to rapidly kill microbes in the cornea to preserve vision.

The molecular orchestra of memory
Feature

The molecular orchestra of memory

April 16, 2026

Calcium, calmodulin and calcium/calmodulin-dependent kinase II form a molecular axis that turns fleeting neural activity into lasting memories. New research shows how memories are stabilized, and possibly even protected or repaired.

Differences in pili structure modulate bacterial behavior
Journal News

Differences in pili structure modulate bacterial behavior

April 14, 2026

Researchers demonstrate how small changes in the structure of hair-like protein appendages can affect the behavior of Acinetobacter bacteria.

Cholesterol regulatory genes predict liver transplant outcomes
Journal News

Cholesterol regulatory genes predict liver transplant outcomes

April 10, 2026

Researchers identify a link between cholesterol-regulating genes and liver transplant success, which could improve donor screening and patient outcomes.

Lipid signatures for a rare neurological disorder
Journal News

Lipid signatures for a rare neurological disorder

April 10, 2026

Researchers find distinct lipid patterns linked to a rare autoimmune neurological disorder, offering hope for effective targeted therapies for patients.

Disease-linked mutations disrupt protein phase behavior
Journal News

Disease-linked mutations disrupt protein phase behavior

April 9, 2026

Researchers find that pathogenic missense mutations are enriched threefold in phrase-separating intrinsically disordered regions of proteins.